Hypoxia in Flight Simulation in Obese Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02636465

Enrollment

Registered

2015-12-21

Start date

2014-03-31

Completion date

2015-02-28

Last updated

2015-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, COPD, OHS

Brief summary

The purpose of this pilot study is to determine whether obese adults,obese (BMI\>30 kg/m2) with obesity hypoventilation or obese COPD-patients do undergo oxygen desaturation under flight simulation and if the hypoxic altitude simulation test is as effective as the hypoxic chamber test.

Interventions

OTHERflight simulationin obese healthy adults or obese patients with or without COPD, OHS

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* age ≥ 18 years * patients with COPD (GOLD I-IV Group A-D) with obesity (BMI\> 30kg/m2), obese healthy adults with BMI\> 30kg /m2, patients with Obesity hypoventilation syndrome * informed consent provided

Exclusion criteria

* patients less than BMI \<30 kg/m2 with or without COPD, OHS * Age \< 18 years * pregnancy, lactation * any medical, psychological or other condition restricting the patient's ability to provide informed consent * participation in another clinical trial

Design outcomes

Primary

Measure	Time frame
desaturation (SaO2 in %) in flight simulation in obese patients	one hour each patient

Secondary

Measure	Time frame
desaturation (SaO2 in %) in hypoxic chamber test versus hypoxia altitude Simulation test	one hour each patient

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026